肌内注射缓释型棕榈酸帕潘立酮:对其用于精神分裂症治疗的综述
Extended-Release Intramuscular Paliperidone Palmitate: A Review of its Use in the Treatment of Schizophrenia
Extended-release intramuscular paliperidone palmitate (Xeplion®; Invega® Sustenna®) [henceforth referred to as intramuscular paliperidone palmitate] is a long-acting injectable (LAI) formulation of the well established atypical antipsychotic agent paliperidone (9-hydroxyrisperidone), which is the major active metabolite of risperidone. This article reviews, from an EU perspective, the therapeutic efficacy and tolerability of intramuscular paliperidone palmitate in the treatment of adults with schizophrenia, and the pharmacology of paliperidone that is relevant to the intramuscular formulation.
学科代码:精神病学 关键词:肌内注射缓释型棕榈酸帕潘立酮:对其用于精神分裂症治疗的综述
来源: Eclips
来源: Eclips
Eclips介绍:Eclips由权威专家阅读世界顶级医学期刊(包括New England Journal of Medicine, The Lancet, JAMA, BMJ 等)后筛选出最顶尖的文章,并总结、分级和点评,为繁忙的临床医生提供最快、最有效的前沿医学信息,并同时提供临床医生参与点评文献和同行互动交流的学术平台。 请点击申请试用并填写联系信息,我们将每月为前100位申请者发送带有用户名、密码及网页链接的电子邮件,请您注意查收!感谢您的参与及使用! 马上访问Eclips网站http://eclips.consult.com/
顶一下(0)
- 您可能感兴趣的文章
-